Puma Biotechnology Inc Common Stock (NASDAQ: PBYI) last traded at $9.24, up 1.43% on the session. The quote above updates while this page is open; the figures below are drawn from Puma Biotechnology Inc Common Stock’s own filings and are restated only when a new one is published.
Puma Biotechnology Inc Common Stock trades on NASDAQ under the ticker PBYI. Its market capitalisation is $476.97 million.
Valuation measures for Puma Biotechnology Inc Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $476.97M |
|---|---|
| Enterprise value | $494.62M |
| P/E ratio | 17.77 |
| Price / sales | 2.06 |
| Price / book | 3.44 |
| Beta | 0.57 |
Trailing-twelve-month figures tagged in Puma Biotechnology Inc Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $231.24M |
|---|---|
| Net income (TTM) | $26.72M |
| EPS (TTM) | $0.520 |
| Operating margin | 13.16% |
| Return on equity | 19.28% |
| Cash | $36.54M |
Range and volume for PBYI over the past 52 weeks.
| 52-week high | $9.51 |
|---|---|
| 52-week low | $4.30 |
| Volume | 241.8K |
| Average volume | 316.1K |
| Previous close | $9.11 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.